# Entia Biosciences, Inc. (ERGO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ERGO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2016 | $ 365.2K | $ -2.03M | $ -993.6K | $ 1.05M | $ -1.97M |
| 2015 | $ 487.1K | $ -3.18M | $ -783.2K | $ 279.2K | $ -791.2K |
| 2014 | $ 927.4K | $ -3.25M | $ -1.03M | $ 418.1K | $ -116.5K |
| 2013 | $ 447.6K | $ -4.42M | $ -1.18M | $ 423.0K | $ -949.6K |
| 2012 | $ 533.1K | $ -1.83M | $ -561.8K | $ 456.3K | $ -648.3K |
| 2011 | $ 592.6K | $ -2.54M | $ -371.4K | $ 332.8K | $ -259.8K |
| 2010 | $ 578.5K | $ -2.03M | $ -879.7K | $ 406.7K | $ -305.2K |
| 2009 | $ 102.4K | $ -1.05M | $ -1.13M | $ 16.7K | $ 365.1K |
| 2008 | $ 0 | $ -191.0K | $ -443.9K | $ 16.5K | $ 440.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.53 |
| Liabilities / Eq | -1.22 |
| Current Ratio | 0.11 |

## Other views

- [Metrics](https://sponda.capital/en/ERGO.md)
- [Charts](https://sponda.capital/en/ERGO/charts.md)
- [Compare](https://sponda.capital/en/ERGO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.